Chemical and analytical methods
1 H NMR spectra were recorded on Bruker DPX 400 or 500 spectrometers in deuterated chloroform or deuterated dimethyl sulfoxide or deuterated methanol operating at 400 and 500
MHz respectively. 13 C NMR spectra were recorded on Bruker 400 or 500 spectrometers operating at 100 and 125 MHz respectively. Chemical shifts are quoted relative to residual solvent (7.26 ppm for deuterated chloroform and 77.0 ppm for 13 C of deuterated chloroform, 2.54 ppm for deuterated dimethyl sulfoxide and 40.45 ppm for 13 C of deuterated dimethyl sulfoxide, 3.31 for deuterated methanol and 49.01 for 13 C deuterated methanol) and coupling constants (J) are given in Hz. The following abbreviations are used singularly or in combination to indicate the multiplicity of signals: s singlet, d doublet, t triplet,uartet, m multiplet and b broad. NMR spectra were acquired at 300 K unless otherwise indicated. All coupling constants are reported to the nearest 0.5 Hz. High resolution mass spectroscopic (HRMS) analyses were measured on a Micromass Q-TOF or a Micromass LCT Premier spectrometer. Infra-red spectra were recorded on a Perkin-Elmer 1600 FT IR spectrometer.
The sample was prepared neat or as a solution in the solvent indicated. Selected absorption maxima (νmax) are reported in wavenumbers (cm -1 ).Melting points were determined on a Buchi B-545 melting point apparatus and are uncorrected. Reactions were carried out in oven-dried glassware under an atmosphere of nitrogen with dry, freshly distilled solvents.
Freeze / thaw degassed solvent was frozen with liquid nitrogen and allowed to partially thaw under vacuum. This was repeated 3 times. Tetrahydrofuran was distilled from LiAlH 4 with triphenylmethane as indicator. Rt (rt) refers to ambient temperature. Temperatures of 0°C
were maintained using an ice-water bath and temperatures below 0°C were maintained using an acetone-card ice bath. Reactions involving microwave irradiation were performed in 10 cm 3 were isolated as a mixture (7) 3-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)prop-1-ene 5 (0.56 g, 2.6 mM), NaHCO 3 6-(3-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)propyl)-2-heptyl-3-hydroxyquinolone (8) Intermediates 6 and 7 were combined (0.37 g, 0.57 mM) and dissolved in methanol (25 mL) in a round bottom flask (100 mL). 10% Palladium on activated carbon (50 mg) was added and the air from the round bottom flask was evacuated under vacuum and replaced with hydrogen gas from a balloon, this process was repeated 3 times. (3 mg, 6 .7 x 10-6 M) was dissolved in anhydrous DMF (1 mL). The sepharose beads (1 mL) in an isopropanol suspension were filtered and washed with DMF (3 x 2 mL). The beads were then added to the DMF solution of 8 followed by triethylamine (10 µL). The reaction mixture was left to stir at rt for 2 hr, and the phases were allowed to settle, LCMS analysis of the solution indicated that 8 was no longer present in solution. Ethanolamine (15 µL) was added to block the remaining NHS sites on the beads and the reaction mixture was left to stir for a further 2 hr. Water (3 mL) was added to the reaction mixture and the beads were filtered and washed with water (3 x 3 mL) to remove residual DMF. The beads were then collected and suspended in isopropanol (1 mL) and stored at 4 o C until use for biological assays.
2-(2-(2-azidoethoxy)ethoxy)ethanol
Sodium azide (2.0 g, 31.7 mM) was added to commercially available 2-2-(Chloroethoxy)ethoxy)ethanol (4 g, 23.8 mM) dissolved in anhydrous DMF (20 mL) at rt.
The reaction mixture was heated to 100 o C for 5 hr with stirring under nitrogen. The reaction mixture was allowed to cool to rt and the DMF was removed by spin evaporation under vacuum. The remaining residue was portioned between water (20 mL) and CH 2 Cl 2 (20 mL) and left to stir for 10 min. The aqueous phase was extracted again with CH 2 Cl 2 (2 x 50 mL).
The organic phases were combined dried (MgSO 4 ), filtered and the solvent was removed by spin evaporation under vacuum to give the desired product as a pale yellow oil 4.1 g (100 %). 
2-(2-(2-propoxyethoxy)ethoxy)ethanamine
The same procedure for 6-(3-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)propyl)-2-heptyl-3-hydroxyquinolone (8) was followed except the reaction was left to stir overnight and the product was purified by column chromatography on alumina, (MeOH : CH 2 Cl 2 ) increasing methanol gradient (3:197) , (3:97) and (1:9). The desired product was isolated as colourless oil 0.165 g, (62 %). Linker only control Attachment to the sepharose beads was carried out as described for the PQS affinity probe.
6-Bromo-2-heptylquinolin-4(1H)-one (9) 6-Bromo-2-heptylquinolin-4(1H)-one 9 was prepared by a Conrad-Limpach cyclisation similar to the procedure described for HHQ by Woschek et. al. 3 A solution of methyl 3-oxodecanoate (2.00 g, 10mmol, 1eq.), 4-bromoaniline (1.72 g, 10 mmol, 1 eq.) and PTSA (40 mg, 0.23 mmol, 0.023 eq.) in hexane (11.8 mL) was heated at reflux with stirring using a dean and stark water separator for 5 hr. The solvents were removed under reduced pressure and the residue was added dropwise to refluxing diphenyl ether (2.4 mL). After 30 min the MeOH was removed under reduced pressure and diethyl ether (10 mL) was added. The precipitate was filtered, washed with diethyl ether (2x 20 mL) and dried in vacuum to give 9
(1.27 g, 3.95 mmol, 39%) as a pink powder which was used without further purification. (Benzyloxy)-6-bromo-2-heptylquinoline (10) A solution of 9 (500 mg, 1.56 mmol, 1 eq.) in DMF (10 mL) was cooled to 0 o C and NaH (60% dispersion in mineral oil, 93 mg, 2.33 mmol, 1.5 eq.) was added. After 15 min benzyl bromide (0.18 mL, 1.56 mmol, 1 eq.) was added and the reaction was allowed to warm to room temperature and stirred for a further 2 hr. 
